These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effects of platelet-activating factor, thromboxane A2 and leukotriene D4 on isolated perfused rat liver. Cui S; Shibamoto T; Liu W; Takano H; Kurata Y Prostaglandins Other Lipid Mediat; 2006 Jul; 80(1-2):35-45. PubMed ID: 16846785 [TBL] [Abstract][Full Text] [Related]
23. Platelet-activating factor-induced coronary constriction in the isolated perfused guinea pig heart and antagonistic effects of the PAF antagonist WEB 2086. Felix SB; Steger A; Baumann G; Busch R; Ochsenfeld G; Berdel WE J Lipid Mediat; 1990; 2(1):9-20. PubMed ID: 2133268 [TBL] [Abstract][Full Text] [Related]
24. [Current status of the myocardial depressant factor (MDF) and shock]. Favaro R; Pelaia P Minerva Anestesiol; 1979; 45(7-8):594-600. PubMed ID: 548819 [No Abstract] [Full Text] [Related]
25. Effects of leukocyte activation on myocardial vascular resistance. Ito BR; Schmid-Schönbein G; Engler RL Blood Cells; 1990; 16(1):145-63; discussion 163-6. PubMed ID: 2112413 [TBL] [Abstract][Full Text] [Related]
26. Evidence for a role of platelet activating factor in hypovolemic shock in the rat. Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759 [TBL] [Abstract][Full Text] [Related]
27. Cardiac dynamics following shock: role of circulating cardiodepressant substances. Goldfarb RD Circ Shock; 1982; 9(3):317-34. PubMed ID: 7094223 [TBL] [Abstract][Full Text] [Related]
28. Myocardial dysfunction in endotoxin- and E. coli-induced shock: pathophysiological mechanisms. Archer LT Circ Shock; 1985; 15(4):261-80. PubMed ID: 3888434 [TBL] [Abstract][Full Text] [Related]
29. The myocardial depressant factor (MDF) in acute hemorrhagic pancreatitis. Ito K; Ramirez-Schon G; Shah PM; DelGuercio LR; Reynolds BM Trans Am Soc Artif Intern Organs; 1980; 26():149-52. PubMed ID: 7245473 [TBL] [Abstract][Full Text] [Related]
31. A study of the myocardial depressant factor and its relative influence in drug/alcohol mortality. Manning TJ; Williams LE; Lynch VD; Bidanset JH; Drake W; Lukash L J Forensic Sci; 1980 Jul; 25(3):550-63. PubMed ID: 7400768 [TBL] [Abstract][Full Text] [Related]
32. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats. Furlan LE; Johnson G; Siegfried M; Lefer AM J Pharmacol Exp Ther; 1990 May; 253(2):525-9. PubMed ID: 2140129 [TBL] [Abstract][Full Text] [Related]
33. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock. Bitterman H; Yanagisawa A; Lefer AM Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667 [TBL] [Abstract][Full Text] [Related]
34. Arachidonic acid in splanchnic artery occlusion shock. Bridenbaugh GA; Flynn JT; Lefer AM Am J Physiol; 1976 Jul; 231(1):112-9. PubMed ID: 961849 [TBL] [Abstract][Full Text] [Related]
35. [Role of biologically active substances in the pathogenesis of endotoxim shock]. Bardakhch'ian EA; Kirichenko IuG Patol Fiziol Eksp Ter; 1983; (1):79-84. PubMed ID: 6341956 [No Abstract] [Full Text] [Related]
36. Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1. Chłopicki S; Bartuś JB; Gryglewski RJ Pol J Pharmacol; 2002; 54(5):433-41. PubMed ID: 12593530 [TBL] [Abstract][Full Text] [Related]
37. [Pathophysiologic mechanisms of the therapeutic effect of corticosteroids in shock and shock-like states (review of the foreign literature)]. Oblyvach AV Patol Fiziol Eksp Ter; 1978; (3):74-81. PubMed ID: 355991 [No Abstract] [Full Text] [Related]
38. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock. Karasawa A; Rochester JA; Lefer AM Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204 [TBL] [Abstract][Full Text] [Related]